STONERIDGE INC (SRI)

US86183P1021 - Common Stock

6.73  +0.32 (+4.99%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SRI. SRI was compared to 82 industry peers in the Automobile Components industry. SRI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SRI has a valuation in line with the averages, but on the other hand it scores bad on growth.



1

1. Profitability

1.1 Basic Checks

SRI had negative earnings in the past year.
In the past year SRI had a positive cash flow from operations.
In multiple years SRI reported negative net income over the last 5 years.
SRI had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

SRI has a Return On Assets of -1.11%. This is amonst the worse of the industry: SRI underperforms 80.25% of its industry peers.
Looking at the Return On Equity, with a value of -2.72%, SRI is doing worse than 79.01% of the companies in the same industry.
SRI's Return On Invested Capital of 1.99% is on the low side compared to the rest of the industry. SRI is outperformed by 82.72% of its industry peers.
Industry RankSector Rank
ROA -1.11%
ROE -2.72%
ROIC 1.99%
ROA(3y)-0.8%
ROA(5y)1.26%
ROE(3y)-1.88%
ROE(5y)2.49%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

SRI has a Operating Margin of 1.35%. This is amonst the worse of the industry: SRI underperforms 82.72% of its industry peers.
In the last couple of years the Operating Margin of SRI has declined.
Looking at the Gross Margin, with a value of 20.92%, SRI is doing worse than 70.37% of the companies in the same industry.
In the last couple of years the Gross Margin of SRI has declined.
Industry RankSector Rank
OM 1.35%
PM (TTM) N/A
GM 20.92%
OM growth 3YN/A
OM growth 5Y-25.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.77%
GM growth 5Y-6.92%

4

2. Health

2.1 Basic Checks

SRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for SRI has been increased compared to 1 year ago.
The number of shares outstanding for SRI has been reduced compared to 5 years ago.
SRI has a worse debt/assets ratio than last year.

2.2 Solvency

SRI has an Altman-Z score of 2.56. This is not the best score and indicates that SRI is in the grey zone with still only limited risk for bankruptcy at the moment.
SRI's Altman-Z score of 2.56 is in line compared to the rest of the industry. SRI outperforms 54.32% of its industry peers.
SRI has a debt to FCF ratio of 19.31. This is a negative value and a sign of low solvency as SRI would need 19.31 years to pay back of all of its debts.
SRI has a worse Debt to FCF ratio (19.31) than 77.78% of its industry peers.
SRI has a Debt/Equity ratio of 0.72. This is a neutral value indicating SRI is somewhat dependend on debt financing.
SRI has a Debt to Equity ratio of 0.72. This is amonst the worse of the industry: SRI underperforms 82.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 19.31
Altman-Z 2.56
ROIC/WACC0.23
WACC8.69%

2.3 Liquidity

A Current Ratio of 2.44 indicates that SRI has no problem at all paying its short term obligations.
SRI has a better Current ratio (2.44) than 82.72% of its industry peers.
SRI has a Quick Ratio of 1.40. This is a normal value and indicates that SRI is financially healthy and should not expect problems in meeting its short term obligations.
SRI has a Quick ratio of 1.40. This is amongst the best in the industry. SRI outperforms 82.72% of its industry peers.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 1.4

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 33.33% over the past year.
SRI shows a decrease in Revenue. In the last year, the revenue decreased by -5.92%.
SRI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.41% yearly.
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-400%
Revenue 1Y (TTM)-5.92%
Revenue growth 3Y14.62%
Revenue growth 5Y2.41%
Sales Q2Q%-10.22%

3.2 Future

The Earnings Per Share is expected to grow by 137.15% on average over the next years. This is a very strong growth
SRI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.05% yearly.
EPS Next Y177.24%
EPS Next 2Y137.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.08%
Revenue Next 2Y2.05%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SRI. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 10.92, the valuation of SRI can be described as reasonable.
SRI's Price/Forward Earnings ratio is in line with the industry average.
SRI is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.82, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 10.92

4.2 Price Multiples

SRI's Enterprise Value to EBITDA ratio is in line with the industry average.
60.49% of the companies in the same industry are cheaper than SRI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 18.33
EV/EBITDA 6.67

4.3 Compensation for Growth

SRI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SRI's earnings are expected to grow with 137.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y137.15%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SRI!.
Industry RankSector Rank
Dividend Yield N/A

STONERIDGE INC

NYSE:SRI (11/22/2024, 2:12:34 PM)

6.73

+0.32 (+4.99%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap186.35M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.92
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.11%
ROE -2.72%
ROCE
ROIC
ROICexc
ROICexgc
OM 1.35%
PM (TTM) N/A
GM 20.92%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.44
Quick Ratio 1.4
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y177.24%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-5.92%
Revenue growth 3Y14.62%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y